erlotinib hydrochloride has been researched along with aminopropionitrile in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (aminopropionitrile) | Trials (aminopropionitrile) | Recent Studies (post-2010) (aminopropionitrile) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 953 | 4 | 162 |
| Protein | Taxonomy | erlotinib hydrochloride (IC50) | aminopropionitrile (IC50) |
|---|---|---|---|
| Lysyl oxidase homolog 2 | Rattus norvegicus (Norway rat) | 0.127 | |
| Protein-lysine 6-oxidase | Homo sapiens (human) | 0.55 | |
| Protein-lysine 6-oxidase | Bos taurus (cattle) | 1.9953 | |
| Lysyl oxidase homolog 2 | Mus musculus (house mouse) | 0.128 | |
| Lysyl oxidase homolog 3 | Homo sapiens (human) | 0.24 | |
| Lysyl oxidase homolog 2 | Homo sapiens (human) | 0.565 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, E; Daugherty, A; Eguchi, S; Elliott, KJ; Forrester, SJ; Fukuda, Y; Kawai, T; Kobayashi, T; Obama, T; Rizzo, V; Takayanagi, T; Taro, Y; Tsuji, T | 1 |
1 other study(ies) available for erlotinib hydrochloride and aminopropionitrile
| Article | Year |
|---|---|
Epidermal growth factor receptor inhibitor protects against abdominal aortic aneurysm in a mouse model.
Topics: Aminopropionitrile; Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Rupture; Cells, Cultured; Cytoprotection; Disease Models, Animal; Endoplasmic Reticulum Stress; ErbB Receptors; Erlotinib Hydrochloride; Extracellular Matrix; Humans; Interleukin-6; Male; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxidative Stress; Protein Kinase Inhibitors; Quinazolines; Rats, Sprague-Dawley; Time Factors | 2015 |